Substance
ID:361424
Names and Identifiers
IUPAC name
{[(2R,3R,4S,5R)-6-[(2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxy}phosphonic acid
Synonyms
Clindamycin 2-phosphateClindamycin 2-dihydrogen phosphate
IUPAC Traditional name
[(2R,3R,4S,5R)-6-[(2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxyphosphonic acid
Properties
Product Information
Pharmacopeia Traceability
traceable to PhEur C2269000
traceable to USP 1138008
Empirical Formula (Hill Notation)
C18H34ClN2O8PS
Safety Information
RTECS
GF2625000
Safety Statements
36
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
GHS Signal Word
Warning
European Hazard Symbols
Harmful (Xn)MSDS Link
Risk Statements
22
German water hazard class
3
Storage Temperature
-20°C
GHS Hazard statements
H302
Molecule Details
Biochem/physiol Actions
Spectrum of Activity: Gram positive cocci and taxoplasma. Especially active against anaerobic bacteria.Mode of Action: Inhibits protein synthesis in bacterial by binding the 50s ribosomal subunit.
Other Notes
Antibacterial and antiprotozoal antibiotic of the licosamide class.
Spectrum of Activity: Gram positive cocci and taxoplasma. Especially active against anaerobic bacteria.Mode of Action: Inhibits protein synthesis in bacterial by binding the 50s ribosomal subunit.
Other Notes
Antibacterial and antiprotozoal antibiotic of the licosamide class.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data